Sara Di Stefano

About

Dr. Sara Di Stefano is a leading thoracic surgeon whose research focuses on optimizing surgical outcomes for early-stage lung cancer patients. Her work centers on comparative effectiveness of minimally invasive techniques, particularly robotic-assisted thoracic surgery (RATS), video-assisted thoracic surgery (VATS), and traditional open thoracotomy. Her most cited study, "Quality of Life, Postoperative Pain, and Lymph Node Dissection in a Robotic Approach Compared to VATS and OPEN for Early Stage Lung Cancer" (2021, 41 citations), provides critical insights by analyzing perioperative outcomes across 169 patients. This landmark work demonstrates her commitment to evidence-based surgical decision-making, showing how different approaches impact not only oncologic efficacy but also patient-centered outcomes like pain management and quality of life. Dr. Di Stefano’s contributions have helped shape modern thoracic surgery protocols, particularly in understanding the trade-offs between robotic precision and traditional approaches. Her research bridges the gap between technical surgical innovation and meaningful patient recovery, making her work essential reading for surgeons and researchers seeking to improve lung cancer care through comparative effectiveness studies.

Research Focus

Key Achievements

Top Papers

1. 1
   Quality of Life, Postoperative Pain, and Lymph Node Dissection in a Robotic Approach Compared to VATS and OPEN for Early Stage Lung Cancer

   41 citations · 2021

Key Collaborators

Contact & Links